Asia Pacific portable medical devices market will grow by 11.2% annually with a total addressable market cap of $171.83 billion over 2021-2030 owing to the rising demand for portable medical devices, increase in geriatric population, growing incidences of chronic diseases, increasing government support, rising R&D investment and technological advancement.
Highlighted with 35 tables and 58 figures, this 122-page report Asia Pacific Portable Medical Devices Market 2020-2030 by Product Type (Monitoring, Diagnostic Imaging, Therapeutic, Fitness & Wellness), Application (Cardiology, Neurology, Gastrointestinal, Orthopedics), End User (Hospitals, Clinics, Household), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Asia Pacific portable medical devices market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific portable medical devices market in every aspect of the classification from perspectives of Product Type, Application, End User, and Country.

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
Monitoring Devices
o Cardiac Monitoring (further segmented into ECG Management Systems, Stress ECG Monitors, Holter Monitors, Resting ECG System, Event Monitoring Systems)
o Neuromonitoring (further segmented into Electroencephalography (EEG) Machines, Electromyography (EMG) Machines, Intracranial pressure (ICP) Monitors, Cerebral Oximeters, Other Neuromonitoring Devices)
o Respiratory Monitoring (further segmented into Peak Flow Meters, Spirometers, Capnographs)
o Hemodynamic Monitoring Systems
o Vital Sign Monitors
o Fetal Monitoring
o Neonatal Monitoring
o Other Monitoring Devices
Diagnostic Imaging Devices
o X-ray
o Computed Tomography (CT)
o Endoscope
o Ultrasound
Therapeutic Devices
o Insulin Pump
o Image-guided Therapy Systems
o Nebulizer
o Oxygen Concentrator
Fitness & Wellness Devices

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
Cardiology
Neurology
Gastrointestinal
Orthopedics
Urology
Gynecology
Respiratory
Other Applications

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
Hospitals & Surgical Centers
Clinics
Household
Other End Users

Geographically, the following national/local markets are fully investigated:
Japan
China
South Korea
Australia
India
Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Product Type, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Cooper Surgical
F. Hoffmann-La Roche Ltd.
GE Company
Infineon Technologies AG
Koninklijke Philips N. V
Medtronic Plc
Natus Medical Incorporated
Nox Medical
OMRON Corporation
Qualcomm
Samsung Group
Siemens Healthineers AG
Texas Instruments
VYAIRE
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)